Your session is about to expire
← Back to Search
Theta-burst Stimulation for Memory Improvement in Mild Cognitive Impairment
Study Summary
This trial is testing whether transcranial magnetic stimulation can help improve memory for people with mild cognitive impairment. The study will enroll people with MCI who will be randomly assigned to receive active or sham brain stimulation, where they won't know if they're receiving the real treatment or not.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with dementia.I can perform most daily activities without help.Your score on the PHQ (Patient Health Questionnaire) is higher than 7.I have never had a stroke, traumatic brain injury, epilepsy, Huntington's, or Parkinson's.I can perform most daily activities without help, despite my memory issues.I live on my own without needing daily help.I may be taking benzodiazepines, depending on the dose it might be okay.You use your right hand more often than your left hand.I do not speak English.I cannot have an MRI due to claustrophobia, metal in my body, recent surgery, certain implants, or past bad MRI results.I am currently taking a sedating antihistamine like Benadryl.I am currently taking medication for muscle spasms or bladder issues.I am not taking medications like certain antidepressants that have strong anticholinergic or antihistaminic effects.I can see and hear well enough for brain function tests.I am between 55 and 90 years old.I haven't changed my mental health meds in the last month.I do not have major psychiatric or neurological disorders affecting my thinking.I have undergone TMS treatment before.You have a current or past problem with alcohol or drug abuse.I have high blood pressure or heart disease that is not well-managed.You have had problems with alcohol or drugs (excluding nicotine and caffeine) within the last six months.You have not gotten enough sleep.I have not had a head injury or diseases affecting my brain.I have been diagnosed with mild cognitive impairment.You have been experiencing memory problems and have reported them yourself, with a positive score on a memory function questionnaire.
- Group 1: Active TBS
- Group 2: Sham TBS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment involve participants aged sixty or above?
"To be eligible for this clinical trial, patients must fall within the age range of 55 to 90. There are 28 trials with participants below 18 and an additional 551 for those above 65 years old."
What type of participants would best suit this trial?
"This medical trial is recruiting a cohort of 70 elderly patients who display signs of cognitive decline, ranging between 55 and 90 years old. Eligible participants must meet the aforementioned age requirements in addition to demonstrating right-handedness, providing informed consent for longitudinal study, meeting DSM-5 criteria for mild neurocognitive disorder (NCD), being generally healthy with no abnormalities interfering with the procedure, displaying proficiency in English language reading/writing/speaking skills as well as sufficient visual/auditory acuity that allows running neuropsychological tests, living independently without requiring assistance from others and exhibiting subjective memory deficits evidenced by self-report or positive score on Memory"
Is there still opportunity for participants to partake in this research?
"Affirmative, the clinicaltrials.gov page shows that this research endeavour is actively looking for participants. This study was initially announced on January 26th 2021 and last modified on April 13th 2022; it seeks to enroll 70 patients at a single site."
What is the scope of enrolment for this medical experiment?
"Affirmative. Clinicaltrials.gov lists the trial as currently open for enrollment, with a start date of January 26th 2021 and an update on April 13th 2022. The experiment requires 70 individuals to be recruited from 1 centre."
Share this study with friends
Copy Link
Messenger